Inarigivir soproxil

Products

Inquiry

Cat. No.: IBDI-433694

Inarigivir soproxil (SB9200) is an agonist of innate immunity and shows potent antiviral activity against resistant HCV variants, with EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems. Inarigivir soproxil, an orally bioavailable proagent of SB 9000, has broad-spectrum antiviral activity against RNA viruses including HCV, norovirus, respiratory syncytial virus and influenza and HBV.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	HCV \| HBV
Molecular Weight	703.62
Appearance	Solid
Synonyms	SB9200, GS-9992
SMILES	CO[[email protected]]1[[email protected]](N(C=CC2=O)C(N2)=O)O[[email protected]](CO)[[email protected]]1OP(OC[[email protected]]3O[[email protected]@H](N4C5=NC=NC(N)=C5N=C4)C[[email protected]@H]3O)(SCOC(OC(C)C)=O)=O
Purity	99.55%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.